A significant structural change in the PBS, which the Government attempted to blunt with 60-day dispensed quantities, is arguably the main growth driver in spending on the program. We discuss the change, which along with others, represents a major reversal in a decades-long approach to medicines access.
Latest Video
New Stories
-
Moderna Announces the awardees for its 2024 Australia Fellowship Program
November 11, 2024 - - Latest News -
Mark Butler announces the creation of hybrid national program for RSV vaccine
November 11, 2024 - - Latest News -
Patients win when health ministers do what they are elected to do
November 11, 2024 - - Latest News -
Pharmac makes cancer therapy the 26th funded since budget boost
November 11, 2024 - - BioPharma -
Lundbeck announces its new leadership for Australia and NZ
November 8, 2024 - - Latest News -
ACCC will not oppose Sigma-Chemist Warehouse merger, subject to undertaking
November 8, 2024 - - Latest News -
AusBiotech and MTPConnect launch joint discussion paper on life science growth issues
November 8, 2024 - - Latest News